Advertisement

Central European Journal of Medicine

, Volume 7, Issue 1, pp 25–29 | Cite as

Alteration of secretory IgA in human breast milk and stool samples after the intake of a probiotic — report of 2 cases

Case Report
  • 82 Downloads

Abstract

Only a few studies reveal immunological changes in breast milk after the intake of probiotic and none focus on secretory IgA (sIgA). The aim our report was to investigate the levels of sIgA in human breast milk and stools before and after 4 weeks of probiotic intake in a patient with ulcerative colitis (UC) and a control. The study included 2 lactating women: 1 with UC and 1 control. Both received daily 3.75 billion viable Lactobacillus bulgaricus for 28 days. SIgA was measured in breast milk and stools before and after the probiotic intake. The concentration of sIgA in breast milk before the probiotic intake in UC was 408.5 vs 137.4 µg/ml in contol. Fecal sIgA in UC was 420 vs 274 µg/ml in control. After 28 days of probiotic intake there was a decrease in breast milk sIgA in UC but an increase in control — 266.7 vs 914 µg/ml respectively. There was an increase in fecal sIgA both in UC and control — 674.4 vs 1033 µg/ml. It is tempting to speculate that the different sIgA secretion towards the probiotic may be a result of an altered mucosal immune response in UC.

Keywords

Human breast milk Secretory IgA Probiotic Ulcerative colitis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Strober W., Kelsall B., Marth T., Oral tolerance, J. Clin. Immunol., 1998, 18, 1–30PubMedCrossRefGoogle Scholar
  2. [2]
    Vaz N., Faria A.M.C., Verdolin B.A., Carvalho C.R., Immaturity, Ageing and Oral Tolerance, Scand. J. Immunology, 1997, 46, 225–229CrossRefGoogle Scholar
  3. [3]
    Weiner H.L., Oral tolerance, an active immunologic process mediated by multiple mechanisms, J. Clin. Invest., 2000, 106, 1031–1038CrossRefGoogle Scholar
  4. [4]
    Goldblum R., Hanson L., Brandtzaeg P., The mucosal defense system, In: Stiehm E., (Ed.), Immunological Disorders in Infants and Children, 3rd ed., Saunders, Philadelphia, 1996Google Scholar
  5. [5]
    Brandtzaeg P. The secretory immunoglobulin system: regulation and biological significance, In: Isaacs C., Davis M., Hanson L., Wright A. (Eds.), Research Agenda for the Millenium: Integrating Population Outcomes, Biological Mechanisms and Research Methods in the Study of Human Milk and Lactation, Kluwer Academic/Plenum Publ., San Diego, 2002Google Scholar
  6. [6]
    Brandtzaeg P., Pabst R., Let’s go mucosal: communication on slippery ground, Trends Immunology, 2004, 25, 570–577CrossRefGoogle Scholar
  7. [7]
    Fagarasan S., Honjo T., Intestinal IgA Synthesis: Regulation of Front-line Body Defenses, Nat. Rev. Immunology., 2003, 3, 63–72CrossRefGoogle Scholar
  8. [8]
    Picker L.J., Butcher E.C., Physiological and Molecular Mechanisms of Lymphocyte Homing, Annu. Rev. Immunol, 1992, 10, 561–591PubMedCrossRefGoogle Scholar
  9. [9]
    Kaetzel C.S., Robinson J.K., Chintalacharuvu K.R., Vaerman J.P., Lamm M.E., The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA, Proc Natl. Acad. Sci., 1991, 88, 8796–8800PubMedCrossRefGoogle Scholar
  10. [10]
    Hanson L.A., Dahlman-Hoglund A., Karlsson M., Lundin S., Dahlgren U., Telemo E., Normal microbial flora of the gut and the immune system, In: Hanson L.A., Yolken R.H. (Eds.), Probiotics, Other Nutritional Factors, and Intestinal Microflora, Lippincott-Raven Publishers, Philadelphia, 1999Google Scholar
  11. [11]
    Hanson L.A., Korotkova M., The role of breastfeeding in prevention of neonatal infection, Semin. Neonatol., 2002, 7, 275–281PubMedGoogle Scholar
  12. [12]
    Ghosh S., van Heel D., Playford R.J., Probiotics in IBD: is it all gut flora modulation?, Gut, 2004, 53, 620–622PubMedCrossRefGoogle Scholar
  13. [13]
    Bogunovic M., Dave S.H., Tilstra J.S., Chang D.T., Harpaz N., Xiong H. et al., Enteroendocrine cells express functional toll-like receptors, Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 3, 76–84Google Scholar
  14. [14]
    Isolauri E., Sutas Y., Kankaanpaa P., Avilommi H., Salminen S., Probiotics: effects on immunity, Am. J. Clin. Nutr., 2001, 73, 444S–450SPubMedGoogle Scholar
  15. [15]
    Aldinucci C., Bellussi L., Monciatti G., Passàli G.C., Salerni L., Passàli D. et al, Effects of dietary youghurt on immunological and clinical parameters of rhinopathic patients, Eur. J. Clin. Nutr., 2002, 56, 1155–1161PubMedCrossRefGoogle Scholar
  16. [16]
    Arunachalam K., Gill H.S., Chandra R.K., Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019), Eur. J. Clin. Nutr., 2000, 54, 263–267PubMedCrossRefGoogle Scholar
  17. [17]
    Isolauri E., Arvola T., Sutas Y., Moilanen E., Salminen S., Probiotics in the management of atopic eczema, Clin. Exp. Allergy, 2000, 30, 1604–1610PubMedCrossRefGoogle Scholar
  18. [18]
    Kalliomaki M., Salminen S., Poussa T., Arvilommi H., Isolauri E., Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo controlled trial, Lancet, 2003, 361, 1869–1871PubMedCrossRefGoogle Scholar
  19. [19]
    Schultz M., Göttl C., Young R.J., Iwen P., Vanderhoof J.A., Administration of oral probiotic bacteria to pregnant women causes temporary infantile colonization, J. Pediatr. Gastroenterol. Nutr., 2004, 38, 244–246CrossRefGoogle Scholar
  20. [20]
    Rautava S., Kalliomäki M., Isolauri E., Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic disease in the infant, J. Allergy Clin. Immunol., 2002, 109, 119–121PubMedCrossRefGoogle Scholar

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  1. 1.Clinic of GastroenterologySt. Ivan Rilsky University HospitalSofiaBulgaria
  2. 2.Clinic of Clinical ImmunologyUniversity Hospital AlexandrovskaSofiaBulgaria

Personalised recommendations